Compare OLED & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLED | IRTC |
|---|---|---|
| Founded | 1985 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 1996 | 2016 |
| Metric | OLED | IRTC |
|---|---|---|
| Price | $89.70 | $126.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $125.00 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 744.1K | 645.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | 9.25 | ★ 61.71 |
| EPS | ★ 1.82 | N/A |
| Revenue | $650,611,000.00 | ★ $747,138,000.00 |
| Revenue This Year | $5.88 | $19.60 |
| Revenue Next Year | $10.36 | $15.94 |
| P/E Ratio | $49.98 | ★ N/A |
| Revenue Growth | 0.45 | ★ 26.24 |
| 52 Week Low | $76.42 | $100.85 |
| 52 Week High | $153.38 | $210.01 |
| Indicator | OLED | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. The large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.